pentobarbital will lessen the level or outcome of buprenorphine subdermal implant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Carefully. Watch sufferers already on buprenorphine subdermal implant who demand freshly-initiated cure with CYP3A4 inducer for indications and signs of withdrawal.Although the clinical l